Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

NCT02559024 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
4
Enrollment
OTHER
Sponsor class

Stopped Drug expired and access to additional supply ended. PI left the institution shortly afterwards and the study will not be re-activated. Only 4 patients were enrolled.

Conditions

Interventions

Sponsor

Providence Health & Services

Collaborators